Angiotensin receptor blockers mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Angiotensin Receptor Blockers Mechanism of Action
Blocking Angiotensin II at the AT1 Receptor
Angiotensin receptor blockers (ARBs) work by selectively blocking the binding of angiotensin II, a hormone that raises blood pressure, to the angiotensin type 1 (AT1) receptor. This action prevents angiotensin II from causing blood vessel constriction, salt and water retention, and other effects that increase blood pressure and can harm the heart and kidneys. Importantly, ARBs do not block the angiotensin type 2 (AT2) receptor, whose function is less well understood but may have protective effects in some tissues 1236+2 MORE.
Effects on the Renin-Angiotensin-Aldosterone System (RAAS)
The RAAS is a key regulator of blood pressure, fluid balance, and sodium levels. By blocking the AT1 receptor, ARBs disrupt the classic angiotensinogen/renin/ACE/angiotensin II/AT1/aldosterone axis, which is responsible for many of the harmful effects seen in hypertension, heart failure, and kidney disease. This blockade not only lowers blood pressure but also helps prevent end-organ damage, such as in the heart and kidneys 3568.
Benefits Beyond Blood Pressure Reduction
ARBs provide benefits that go beyond simply lowering blood pressure. They help reduce inflammation, oxidative stress, and vascular remodeling, which can protect against heart failure, stroke, and kidney disease. ARBs also improve endothelial function and may reduce the risk of in-stent restenosis by inhibiting inflammatory changes and the recruitment of vascular progenitor cells 3467.
Clinical Implications and Therapeutic Use
ARBs are as effective as other antihypertensive drugs, including ACE inhibitors, in lowering blood pressure. They are often used in patients who cannot tolerate ACE inhibitors due to side effects like cough or angioedema. ARBs may also offer more complete inhibition of angiotensin II effects compared to ACE inhibitors, and they are particularly useful for patients with hypertension, heart failure, and diabetic nephropathy 1689.
Additional Mechanisms and Ongoing Research
Recent research suggests that ARBs may have additional effects, such as influencing angiogenesis (the formation of new blood vessels) and providing neuroprotection in stroke. Some studies indicate that ARBs can stimulate unopposed AT2 receptors, which may be beneficial in certain conditions like ischemic stroke. The full range of ARB actions is still being explored, and ongoing studies continue to clarify their benefits across various diseases 5710.
Conclusion
Angiotensin receptor blockers lower blood pressure and protect organs by selectively blocking the AT1 receptor, preventing the harmful effects of angiotensin II. Their benefits extend beyond blood pressure control, offering protection against heart, kidney, and vascular diseases, and they are a valuable alternative for patients who cannot tolerate ACE inhibitors. Ongoing research continues to uncover new mechanisms and therapeutic uses for ARBs.
Sources and full results
Most relevant research papers on this topic
Angiotensin II Type 1 Receptor Blockade Attenuates In-Stent Restenosis by Inhibiting Inflammation and Progenitor Cells
Angiotensin II type 1 receptor blocker reduces in-stent restenosis by inhibiting inflammation and reducing recruitment of progenitor cells, offering a novel mechanism of action for its clinical use.
Angiotensin II-receptor blockers: clinical relevance and therapeutic role.
Angiotensin II-receptor blockers (ARBs) offer an alternative to ACE inhibitors for managing hypertension and offer renal protection in diabetic nephropathy, offering a potential alternative for patients with heart failure, left ventricular dysfunction after MI, and diabetic nephropathy.
DOI